Akamis Bio Limited is an active company incorporated on 17 November 2006 with the registered office located in Sandwich, Kent. Akamis Bio Limited was registered 18 years ago.
Akamis Bio is a clinical-stage oncology company that develops Tumor-Specific Immuno-Gene (T-SIGn®) therapeutics aimed at enabling the immune system to target and eliminate solid tumors..
Financials
Net Assets, Total Assets & Total Liabilities (2015–2024)
Registered office address changed from Akamis House 4-10 the Quadrant Barton Lane Abingdon Oxfordshire OX14 3YS United Kingdom to Office 20, Second Floor Innovation House, Innovation Way Discovery Park Sandwich Kent CT13 9FF on 7 October 2025
Submitted on 7 Oct 2025
Group of companies' accounts made up to 31 December 2024
Submitted on 5 Sep 2025
Statement of capital following an allotment of shares on 17 April 2025
Submitted on 6 May 2025
Purchase of own shares.
Submitted on 12 Feb 2025
Notification of Fengsheng Che as a person with significant control on 17 October 2024
Submitted on 12 Feb 2025
Cancellation of shares. Statement of capital on 20 January 2025
Submitted on 12 Feb 2025
Withdrawal of a person with significant control statement on 12 February 2025
Submitted on 12 Feb 2025
Confirmation statement made on 2 February 2025 with updates
Submitted on 12 Feb 2025
Statement of capital following an allotment of shares on 10 December 2024
Submitted on 13 Dec 2024
Notification of a person with significant control statement